Sign In
Buy BBI
$1.94
+0 (+0%)
At Close: Feb 07, 2023
The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes
12:00am, Wednesday, 01'st Jul 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 30)
ADC Therapeutics SA (NYSE:...
BBI team ready to present final report
04:55pm, Tuesday, 30'th Jun 2020
NAIROBI, Kenya Jun 30 – The Building Bridges Initiative Steering Committee says it has completed its task, and is now ready to present its final report. Joint Secretaries of the Taskforce, Martin Ki
BBI team seeks term extension to complete task
08:05am, Tuesday, 30'th Jun 2020
NAIROBI, Kenya Jun 30 – The Steering Committee on the Implementation of the Building Bridges Initiative Report has sought an extension of its tenure to finalise on their report before handing it ove
Robert Elias Joins The Exclusive Haute Lawyer Network By Haute Living
03:10am, Thursday, 25'th Jun 2020
Robert Elias has joined the exclusive Haute Lawyer Network by Haute Living as an expert in Real Estate Law in South Florida.
MIAMI (PRWEB) June 24, 2020
Robert Elias, leading Real Estate Law atto
Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering
02:00am, Thursday, 18'th Jun 2020
BOULDER, Colo., June 17, 2020 -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated.
Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public Offering
12:00am, Thursday, 18'th Jun 2020
BOULDER, Colo., June 17, 2020 (GLOBE NEWSWIRE) -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on...
BRICKELL BIOTECH, INC. : Regulation FD Disclosure (form 8-K) | MarketScreener
10:42am, Monday, 15'th Jun 2020
Brickell Biotech, Inc. (“Brickell”) (BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating s
One of Wales' leading life sciences firms BBI expands with German acquisition
10:53am, Thursday, 04'th Jun 2020
The Crumlin headquartered firm has acquired DIARECT
BRICKELL BIOTECH, INC. : Change in Directors or Principal Officers (form 8-K) | MarketScreener
09:01pm, Tuesday, 02'nd Jun 2020What We Know About Selling Sunset Star Maya Vander’s Husband
05:40pm, Monday, 01'st Jun 2020
After some internet sleuthing, Mary's husband's name has been revealed.
Brickell Biotech (NASDAQ:BBI) Is Arguably In A Tricky Situation
12:04pm, Sunday, 31'st May 2020
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
